세계의 장기 이식 시장 - 예측(2024-2029년)

The global organ transplant market is projected to rise at a compound annual growth rate (CAGR) of 9.24% to reach a market valuation of US$43.962 billion by 2029, from US$23.686 billion in 2022.

The global organ transplant market experiences dynamic growth fueled by a multitude of factors. Progress in surgical procedures, organ preservation techniques, immunosuppressive medications, and the emerging realm of xenotransplantation continually broaden the pool of potential recipients and elevate success rates, instilling confidence and driving demand.

A rising global incidence of chronic ailments such as diabetes, hypertension, and cardiac conditions heightens the likelihood of organ failure, thus magnifying the need for transplantations. Ongoing advancements in medical technology continuously refine surgical methodologies and immunosuppressive treatments, rendering organ transplantation increasingly feasible for a broader patient demographic.

Moreover, the expanding geriatric population and increasing public consciousness regarding the significance of organ donation contribute to a growing willingness among individuals to donate their organs posthumously. Numerous governments worldwide are spearheading initiatives aimed at elevating organ donation rates and enhancing accessibility to transplant services.

Market Drivers:

• Increasing cases of acute diseases propels the market.

The global organ transplant market is projected to rise at a high growth rate. The industry is expected to be affected by changing environmental, technological, and governmental regulations, which are anticipated to challenge market growth as well. In addition, the increasing technological advancements and market developments, including product launches, collaborations, agreements, acquisitions, and other related factors.

Owing to the growing demand for innovative tissue transplantation services and organ transplantation to treat organ failure. Many conditions, including severe trauma, blood loss, poisoning, drug abuse, leukemia, sepsis, and other acute illnesses, are typically the cause of organ failure.

Further, public awareness campaigns and initiatives play a crucial role in educating the populace about the importance of organ donation. This educational effort holds promise for boosting the availability of organs, potentially bridging the gap between supply and demand.

The rising prevalence of chronic ailments like kidney failure, liver cirrhosis, heart failure, lung diseases, and diabetes directly correlates with the escalating demand for organ transplants.

Moreover, according to the World Health Organization (WHO), non-communicable diseases (NCDs) contribute significantly to global mortality rates. Cardiovascular diseases top the list, claiming 17.9 million lives annually, followed by cancers (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million, including deaths due to kidney disease resulting from diabetes). These diseases share common risk factors, including tobacco use, physical inactivity, harmful alcohol consumption, unhealthy diets, and air pollution.

Furthermore, statistics from the American Heart Association underline the concerning prevalence of tobacco use, with 16.5% of US high school students and 4.5% of middle school students reporting current tobacco product use. Additionally, 11.5% of US adults admit to using cigarettes daily or occasionally. As the incidence of these diseases rises, so does the demand for replacement organs.

The global organ transplant market operates within a complex framework of interacting factors, presenting significant opportunities alongside notable challenges. Technological innovations, heightened awareness efforts, and ethical considerations will continue to shape the trajectory of this dynamic field, influencing its future growth and development.

• Growing Geriatric Population

As the global population ages, the demand for organ transplants is expected to surge due to the higher prevalence of chronic illnesses among older adults, which often result in organ failure. According to OECD statistics, Germany saw its geriatric population rise from 21.863% in 2020 to 22.134% in 2022. Over the period from 2015 to 2050, the proportion of individuals aged over 60 worldwide is projected to nearly double from 12% to 22%. This demographic shift significantly expands the market for organ donation, as the elderly population requires increased healthcare services to maintain their well-being.

• Innovation in the field

Innovation is thriving in the region, with a robust focus on research and development yielding breakthroughs in various aspects of organ transplantation. Advancements in surgical techniques, immunosuppressive medications, and cutting-edge concepts like xenotransplantation underscore the region's commitment to pushing the boundaries of medical science.

Normothermic perfusion, a pioneering technology in organ preservation, represents a significant stride forward. Unlike traditional cold storage methods, normothermic perfusion employs a warm system, revolutionizing the approach to liver and cardiac transplants, albeit yet to be utilized for kidney transplants.

Furthermore, researchers are at the forefront of exploring revolutionary avenues such as 3D printing technology in organ creation. By harnessing a patient's cells, this innovative approach holds promise in fabricating functional organs, potentially obviating the reliance on donor organs altogether, though still in its nascent stages. Concurrently, the development of novel immunosuppressive drugs signals a leap forward in transplant care. These medications are engineered to be more adept at thwarting organ rejection while mitigating adverse effects on patients, representing a significant advancement in enhancing transplant outcomes and patient well-being.

Market Restraint:

• Shortage of organ donors and high cost of operations

The global organ transplant market grapples with two primary challenges: a shortage of donor organs and the high costs associated with transplantation procedures. Despite concerted efforts to raise awareness about organ donation, the supply of suitable organs falls short of the increasing demand, creating a significant gap for individuals awaiting transplants.

Moreover, the expense of transplantation, encompassing pre-transplant evaluations, surgery, post-operative care, and lifelong immunosuppressive medication, poses a formidable barrier to access for many. While vital for preventing organ rejection, the prolonged use of immunosuppressive drugs post-transplantation presents additional hurdles, with potential adverse side effects and heightened risks of infections and other health complications.

Global organ transplant market segmentation by end-users into hospitals, transplant centers, and others.

The global organ transplant market is segmented by end-users, including hospitals, transplant centers, and other entities. Hospitals serve as the primary treatment hubs where a significant portion of organ transplant procedures take place. Transplant centres, on the other hand, represent specialized healthcare facilities exclusively focused on organ transplantation.

These centers offer a comprehensive array of transplant services and specialized expertise, surpassing what is typically available in general hospitals. Others encompass a smaller subset of end-users, such as ambulatory surgical centers and research institutions. Ambulatory surgical centres may undertake certain types of simpler organ transplant procedures within their scope of services.

North America is anticipated to hold a significant share of the global organ transplant market

North America is expected to maintain a substantial portion of the global organ transplant market, with the United States leading the forefront. Renowned for its sophisticated healthcare infrastructure, the US possesses cutting-edge medical facilities, proficient surgeons, and efficient organ procurement organizations.

Consequently, this leads to a notable increase in the number of transplant procedures conducted. Additionally, the region grapples with a rising prevalence of chronic conditions such as diabetes and heart disease, further expanding the pool of patients necessitating organ transplants.

Market Developments:

• September 2023- UC Davis Health launched a new adult liver transplant program, expanding the existing services of the UC Davis Transplant Center and providing comprehensive care to patients with liver disease.

Market Segmentation:

By Product Type

• Organ preservation solutions
• Transplant diagnostics
• Tissue products
• Others

By Organ Type

• Heart
• Intestine
• Kidney
• Liver
• Lung
• Pancreas

By End-Users

• Hospitals
• Transplant Centers
• Others

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• UK
• Italy
• Others
• Middle East and Africa
• Saudi Arabia
• Israel
• Others
• Asia Pacific
• China
• Japan
• India
• South Korea
• Indonesia
• Taiwan
• Thailand
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base and Forecast Years Timeline
• 1.8. Key benefits to the stakeholder

2. RESEARCH METHODOLOGY

• 2.1. Research Design
• 2.2. Research Process

3. EXECUTIVE SUMMARY

• 3.1. Key Findings
• 3.2. Analyst View

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis
• 4.5. Analyst View

5. GLOBAL ORGAN TRANSPLANT MARKET BY PRODUCT TYPE

• 5.1. Introduction
• 5.2. Organ preservation solutions
  • 5.2.1. Market opportunities and trends
  • 5.2.2. Growth prospects
  • 5.2.3. Geographic lucrativeness
• 5.3. Transplant diagnostics
  • 5.3.1. Market opportunities and trends
  • 5.3.2. Growth prospects
  • 5.3.3. Geographic lucrativeness
• 5.4. Tissue products
  • 5.4.1. Market opportunities and trends
  • 5.4.2. Growth prospects
  • 5.4.3. Geographic lucrativeness
• 5.5. Others
  • 5.5.1. Market opportunities and trends
  • 5.5.2. Growth prospects
  • 5.5.3. Geographic lucrativeness

6. GLOBAL ORGAN TRANSPLANT MARKET BY ORGAN TYPE

• 6.1. Introduction
• 6.2. Heart
  • 6.2.1. Market opportunities and trends
  • 6.2.2. Growth prospects
  • 6.2.3. Geographic lucrativeness
• 6.3. Intestine
  • 6.3.1. Market opportunities and trends
  • 6.3.2. Growth prospects
  • 6.3.3. Geographic lucrativeness
• 6.4. Kidney
  • 6.4.1. Market opportunities and trends
  • 6.4.2. Growth prospects
  • 6.4.3. Geographic lucrativeness
• 6.5. Liver
  • 6.5.1. Market opportunities and trends
  • 6.5.2. Growth prospects
  • 6.5.3. Geographic lucrativeness
• 6.6. Lung
  • 6.6.1. Market opportunities and trends
  • 6.6.2. Growth prospects
  • 6.6.3. Geographic lucrativeness
• 6.7. Pancreas
  • 6.7.1. Market opportunities and trends
  • 6.7.2. Growth prospects
  • 6.7.3. Geographic lucrativeness

7. GLOBAL ORGAN TRANSPLANT MARKET BY END-USERS

• 7.1. Introduction
• 7.2. Hospitals
  • 7.2.1. Market opportunities and trends
  • 7.2.2. Growth prospects
  • 7.2.3. Geographic lucrativeness
• 7.3. Transplant Centers
  • 7.3.1. Market opportunities and trends
  • 7.3.2. Growth prospects
  • 7.3.3. Geographic lucrativeness
• 7.4. Others
  • 7.4.1. Market opportunities and trends
  • 7.4.2. Growth prospects
  • 7.4.3. Geographic lucrativeness

8. GLOBAL ORGAN TRANSPLANT MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. By Product Type
  • 8.2.2. By Organ Type
  • 8.2.3. By End-users
  • 8.2.4. By Country
    • 8.2.4.1. United States
      • 8.2.4.1.1. Market Trends and Opportunities
      • 8.2.4.1.2. Growth Prospects
    • 8.2.4.2. Canada
      • 8.2.4.2.1. Market Trends and Opportunities
      • 8.2.4.2.2. Growth Prospects
    • 8.2.4.3. Mexico
      • 8.2.4.3.1. Market Trends and Opportunities
      • 8.2.4.3.2. Growth Prospects
• 8.3. South America
  • 8.3.1. By Product Type
  • 8.3.2. By Organ Type
  • 8.3.3. By End-users
  • 8.3.4. By Country
    • 8.3.4.1. Brazil
      • 8.3.4.1.1. Market Trends and Opportunities
      • 8.3.4.1.2. Growth Prospects
    • 8.3.4.2. Argentina
      • 8.3.4.2.1. Market Trends and Opportunities
      • 8.3.4.2.2. Growth Prospects
    • 8.3.4.3. Others
      • 8.3.4.3.1. Market Trends and Opportunities
      • 8.3.4.3.2. Growth Prospects
• 8.4. Europe
  • 8.4.1. By Product Type
  • 8.4.2. By Organ Type
  • 8.4.3. By End-users
  • 8.4.4. By Country
    • 8.4.4.1. Germany
      • 8.4.4.1.1. Market Trends and Opportunities
      • 8.4.4.1.2. Growth Prospects
    • 8.4.4.2. France
      • 8.4.4.2.1. Market Trends and Opportunities
      • 8.4.4.2.2. Growth Prospects
    • 8.4.4.3. UK
      • 8.4.4.3.1. Market Trends and Opportunities
      • 8.4.4.3.2. Growth Prospects
    • 8.4.4.4. Italy
      • 8.4.4.4.1. Market Trends and Opportunities
      • 8.4.4.4.2. Growth Prospects
    • 8.4.4.5. Others
      • 8.4.4.5.1. Market Trends and Opportunities
      • 8.4.4.5.2. Growth Prospects
• 8.5. Middle East and Africa
  • 8.5.1. By Product Type
  • 8.5.2. By Organ Type
  • 8.5.3. By End-users
  • 8.5.4. By Country
    • 8.5.4.1. Saudi Arabia
      • 8.5.4.1.1. Market Trends and Opportunities
      • 8.5.4.1.2. Growth Prospects
    • 8.5.4.2. Israel
      • 8.5.4.2.1. Market Trends and Opportunities
      • 8.5.4.2.2. Growth Prospects
    • 8.5.4.3. Others
      • 8.5.4.3.1. Market Trends and Opportunities
      • 8.5.4.3.2. Growth Prospects
• 8.6. Asia Pacific
  • 8.6.1. By Product Type
  • 8.6.2. By Organ Type
  • 8.6.3. By End-users
  • 8.6.4. By Country
    • 8.6.4.1. China
      • 8.6.4.1.1. Market Trends and Opportunities
      • 8.6.4.1.2. Growth Prospects
    • 8.6.4.2. Japan
      • 8.6.4.2.1. Market Trends and Opportunities
      • 8.6.4.2.2. Growth Prospects
    • 8.6.4.3. India
      • 8.6.4.3.1. Market Trends and Opportunities
      • 8.6.4.3.2. Growth Prospects
    • 8.6.4.4. South Korea
      • 8.6.4.4.1. Market Trends and Opportunities
      • 8.6.4.4.2. Growth Prospects
    • 8.6.4.5. Indonesia
      • 8.6.4.5.1. Market Trends and Opportunities
      • 8.6.4.5.2. Growth Prospects
    • 8.6.4.6. Taiwan
      • 8.6.4.6.1. Market Trends and Opportunities
      • 8.6.4.6.2. Growth Prospects
    • 8.6.4.7. Thailand
      • 8.6.4.7.1. Market Trends and Opportunities
      • 8.6.4.7.2. Growth Prospects
    • 8.6.4.8. Others
      • 8.6.4.8.1. Market Trends and Opportunities
      • 8.6.4.8.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisition, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. OrganOx Limited
• 10.2. GlaxoSmithKline Plc.
• 10.3. Pfizer
• 10.4. XVIVO Perfusion AB (Organ Assist B.V.)
• 10.5. Paragonix Technologies Inc.
• 10.6. Novartis AG
• 10.7. Preservation Solution Inc.
• 10.8. Water Medical System LLC
• 10.9. Sanofi S.A
• 10.10. Bridge to Life Ltd.